Development Pipeline

INOVIQ is developing a multi-product portfolio that includes commercial stage exosome isolation products, clinical stage diagnostics for ovarian and breast cancers, and a cutting-edge preclinical CAR-exosome therapeutic program for solid tumours.

NOTE: Development pipeline is indicative only, subject to review                                                              
Exosome = Extracellular Vesicles; IVD = In Vitro Diagnostic; LDT = Laboratory-Developed Test; RUO = Research Use Only